telangiectasia, inflammatory lesions, and ocular manifestations. Among the more recently approved treatments for rosacea — and among products and drug indications under study — “notice there ...

and spider veins (telangiectasia). According to The National Rosacea Society it is estimated that rosacea affects over 16 million Americans and as many as 415 million people worldwide.

Investigators sought to better understand how race and ethnicity was related to the severity of rosacea phenotypes among adults.